Sun Pharmaceutical Industries

News

SUN PHARMACEUTICAL INDUSTRIES NEWS

Sun Pharma arm launches plaque psoriasis treatment drug in Japan

September 23, 2020 12:56 pm

In June this year, Sun Pharma said its subsidiary has got approval from the Japanese government for Ilumya.

Sun Pharma Q1 net loss at Rs 1,655.60 crore

July 31, 2020 5:28 pm

The company had posted a net profit of Rs 1,387.48 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.

Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA region

June 15, 2020 3:11 pm

Under the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA markets and Sun Pharma will be responsible for product supply, it added.

Sun Pharma board approves Rs 1,700 crore share buy-back offer

March 17, 2020 3:17 pm

Sun Pharmaceutical Industries said that the board of directors of the company, at its meeting held on Tuesday has approved the buy-back of its equity shares from the open market at a maximum price of Rs 425 per share.

Sun Pharmaceutical, Sun Pharmaceutical complaint, whistleblower complaint sun pharma, economy news, business news, indian express

Why shares in Sun Pharma are down over 10%

December 03, 2018 1:19 pm

Markets regulator Securities and Exchange Board of India (SEBI) is likely to reopen an insider trading case against Sun Pharmaceutical

USFDA bans import from Sun Pharma facility in Gujarat

March 14, 2014 2:14 am

The company’s Karkhadi facility manufactures antibiotics and active pharmaceutical ingredients (APIs). Sun Pharma has 10 manufacturing sites in India.

Sun Pharma posts R1,276 cr Q1 loss on patent settlement

August 10, 2013 1:48 am

Sun Pharma posts R1,276 cr Q1 loss on patent settlement.

Sun Pharma Q1 net loss at Rs 1,276.10 cr on patent settlement

August 09, 2013 5:13 pm

However,consolidated total income of the company rose to Rs 3,502.73 crore for Q1.

Teva,Sun Pharma to settle Pfizer patent suit for $2.15 billion

June 13, 2013 3:58 am

Pfizer Inc on Wednesday said a $2.15 billion settlement has been reached with Teva Pharmaceuticals Industries of Israel and Sun Pharmaceutical Industries,Mumbai,for patent-infringement damages resulting from their at-risk launches of generic Protonix in the US.